Epirubicin
Overview
Epirubicin is anthracycline antibiotic.It is an anticancerous agent. and has antineoplastic actions similar to doxorubicin. Epirubicin (HCl) is effective in the treatment of different cancers to slow or stop the growth of abnormal cells. Epirubicin (HCl) is used in combination with different anticancerous drugs to obtain most excellent therapeutic effects and reduce toxicity or unwanted effects.
Categories
- 8 Antineoplastics, immunomodulators and drugs used in palliative care
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Epirubicin is contraindicated in conditions like Hypersensitivity.
Back to top
Back to top
Side Effects
Back to top
Dosage
Epirubicin's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 60 to 90 mg/ sq.meter | 75 (75) | As recommended. | IV | Every 3 weeks. |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Epirubicin is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Epirubicin is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Epirubicin
Back to top
Previous Drug Generic - Next Drug Generic